These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10998471)

  • 1. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease.
    Gardemann A; Philipp M; Hess K; Katz N; Tillmanns H; Haberbosch W
    Atherosclerosis; 2000 Oct; 152(2):421-31. PubMed ID: 10998471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals.
    Gardemann A; Mages P; Katz N; Tillmanns H; Haberbosch W
    Atherosclerosis; 1999 Aug; 145(2):315-23. PubMed ID: 10488959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
    Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
    Ferré N; Tous M; Paul A; Zamora A; Vendrell JJ; Bardají A; Camps J; Richart C; Joven J
    Clin Biochem; 2002 May; 35(3):197-203. PubMed ID: 12074827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile.
    Gardemann A; Lohre J; Cayci S; Katz N; Tillmanns H; Haberbosch W
    Atherosclerosis; 2002 Jan; 160(1):167-75. PubMed ID: 11755935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
    Herrmann SM; Blanc H; Poirier O; Arveiler D; Luc G; Evans A; Marques-Vidal P; Bard JM; Cambien F
    Atherosclerosis; 1996 Oct; 126(2):299-303. PubMed ID: 8902155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
    Pan JP; Lai ST; Chiang SC; Chou SC; Chiang AN
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):415-21. PubMed ID: 12433026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
    Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
    J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese.
    Zama T; Murata M; Matsubara Y; Kawano K; Aoki N; Yoshino H; Watanabe G; Ishikawa K; Ikeda Y
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3565-9. PubMed ID: 9437206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.
    Ko YL; Ko YS; Wang SM; Hsu LA; Chang CJ; Chu PH; Cheng NJ; Chen WJ; Chiang CW; Lee YS
    Atherosclerosis; 1998 Dec; 141(2):259-64. PubMed ID: 9862174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease.
    Aynacioglu AS; Kepekci Y
    Int J Cardiol; 2000 Jun; 74(1):33-7. PubMed ID: 10854678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
    Suehiro T; Nakauchi Y; Yamamoto M; Arii K; Itoh H; Hamashige N; Hashimoto K
    Int J Cardiol; 1996 Nov; 57(1):69-73. PubMed ID: 8960946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Chen Q; Reis SE; Kammerer CM; McNamara DM; Holubkov R; Sharaf BL; Sopko G; Pauly DF; Merz CN; Kamboh MI;
    Am J Hum Genet; 2003 Jan; 72(1):13-22. PubMed ID: 12454802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
    Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
    Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients.
    Gardemann A; Weiss T; Schwartz O; Eberbach A; Katz N; Hehrlein FW; Tillmanns H; Waas W; Haberbosch W
    Circulation; 1995 Nov; 92(10):2796-9. PubMed ID: 7586243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.